Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Our lead product is Eroxon®a clinically proven breakthrough treatment for erectile dysfunction
Products FAQs
Futura has two new products in its development pipeline, Eroxon® Intense and WSD4000 for the treatment of sexual dysfunction in men and women.
Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.
WEBCASTS
Videos and webcasts
Shareholder centre
This section contains the latest RNS, news and videos.
Block Listing Six Monthly Return
TR-1: Notification of major holdings
Encouraging New Product Development Pipeline
Read more
33.68p (GB)
Change: -0.33 Last updated: 21:30
Share price information delayed at least 15 minutes
Download our Interim Results 2024
04 November 2024
10 September 2024
©2024 Futura Medical